Compare VALN & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | RGR |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.9M | 617.8M |
| IPO Year | 2021 | 1994 |
| Metric | VALN | RGR |
|---|---|---|
| Price | $5.17 | $39.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.50 | ★ $43.00 |
| AVG Volume (30 Days) | 31.5K | ★ 92.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $546,057,000.00 |
| Revenue This Year | N/A | $2.38 |
| Revenue Next Year | $93.87 | N/A |
| P/E Ratio | ★ N/A | $3,889.00 |
| Revenue Growth | N/A | ★ 1.94 |
| 52 Week Low | $5.06 | $28.33 |
| 52 Week High | $12.25 | $48.21 |
| Indicator | VALN | RGR |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 47.57 |
| Support Level | $5.11 | $38.60 |
| Resistance Level | $6.60 | $40.87 |
| Average True Range (ATR) | 0.25 | 0.86 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 10.45 | 34.68 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.